COVID-19: Here’s How Human Clinical Trials For COVAXIN Are Being Conducted
The experimental novel Coronavirus vaccine has entered the first phase of human trials at several hospitals across the country.
COVAXIN, an experimental novel Coronavirus vaccine developed by Hyderabad-based Bharat Biotech International Ltd. (BBIL), has entered Phase I of human clinical trials. The process commenced at Redkar Hospital in Goa on Monday (July 20) and at a Bhubaneshwar-based institute on Wednesday (July 22). They are two of the 12 centres selected by the Indian Council of Medical Research (ICMR) for conducting Phase I and II of the human clinical trials. On July 17, they began at Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak and some other places.
COVAXIN’s Phase I trials will see participation from 350 people across the country. Of those, a maximum of 100 volunteers will take part in the procedure at AIIMS-Delhi (All India Institute of Medical Sciences). The first 50 will get the first dose of the vaccine. If the vaccine is marked as safe then it will be administered to the other 50 participants. “The results of the first phase are expected in the next two-three months,” said Dr Randeep Guleria, who is overseeing the procedure.
Get the latest COVID-19 news updates on ZEE5.